Real-world effectiveness of vedolizumab vs anti-TNF in biologic-naïve Crohn’s disease patients: a 2-year propensity-score-adjusted analysis from the VEDOIBD-study

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Bernd Bokemeyer, Sandra Plachta-Danielzik, Romina di Giuseppe, Philipp Efken, Wolfgang Mohl, Martin Hoffstadt, Thomas Krause, Axel Schweitzer, Elisabeth Schnoy, Raja Atreya, Niels Teich, Leo Trentmann, Robert Ehehalt, Petra Hartmann, Stefan Schreiber
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/109356
URL:https://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izad138/51012579/izad138.pdf
ISSN:1078-0998OPAC
ISSN:1536-4844OPAC
Parent Title (English):Inflammatory Bowel Diseases
Publisher:Oxford University Press (OUP)
Place of publication:Oxford
Type:Article
Language:English
Year of first Publication:2023
Release Date:2023/11/30
Tag:Gastroenterology; Immunology and Allergy
DOI:https://doi.org/10.1093/ibd/izad138
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Innere Medizin mit Schwerpunkt Gastroenterologie
Latest Publications (not yet published in print):Aktuelle Publikationen (noch nicht gedruckt erschienen)